Skip to main content
NCBI home page
The British Journal of Cancer. Supplement logoLink to The British Journal of Cancer. Supplement
. 1975 Mar;2:152–155.

Marek's disease--the disease and its prevention by vaccination.

P M Biggs
PMCID: PMC2149595  PMID: 170953

Abstract

Marek's disease (MD) is a common lymphoproliferative disease of the domestic chicken caused by a cell associated herpesvirus. Vaccines used for the prophylaxis of MD have been derived from non-pathogenic field Marek's disease virus (MDV), pathogenic MDV and the herpesvirus of turkeys (HVT). Vaccines derived from MDV have been developed by attenuation of virus strains which produce the acute form of MD and virus strains which produce the classical form. They have also been developed by suitable modification, where necessary, of non-pathogenic MDV. All MDV derived vaccines have to be used in the cell associated form. The turkey herpesvirus vaccine can be used in either the cell associated or cell free lyophilized form. All these types of vaccine appear to be safe and to provide significant levels of protection under field conditions.

Full text

PDF
152

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ball R. F., Hill J. F., Lyman J., Wyatt A. The effect of early natural exposure to Marek's disease on immunization of breeders by vaccination. Poult Sci. 1971 Mar;50(2):648–649. doi: 10.3382/ps.0500648. [DOI] [PubMed] [Google Scholar]
  2. Biggs P. M., Payne L. N., Milne B. S., Churchill A. E., Chubb R. C., Powell D. G., Harris A. H. Field trials with an attenuated cell associated vaccine for Marek's disease. Vet Rec. 1970 Dec 5;87(23):704–709. doi: 10.1136/vr.87.23.704. [DOI] [PubMed] [Google Scholar]
  3. Blaxland J. D., Macleod A. J., Baxendale W., Hall T. Observations on field trials with an experimental attenuated Marek's disease virus vaccine. Vet Rec. 1972 Apr 15;90(16):431–437. doi: 10.1136/vr.90.16.431. [DOI] [PubMed] [Google Scholar]
  4. Calnek B. W., Hitchner S. B., Adldinger H. K. Lyophilization of cell-free Marek's disease herpesvirus and a herpesvirus from turkeys. Appl Microbiol. 1970 Nov;20(5):723–726. doi: 10.1128/am.20.5.723-726.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chubb R. C., Churchill A. E. Effect of maternal antibody on Marek's disease. Vet Rec. 1969 Sep 13;85(11):303–305. doi: 10.1136/vr.85.11.303. [DOI] [PubMed] [Google Scholar]
  6. Churchill A. E., Chubb R. C., Baxendale W. The attenuation, with loss of oncogenicity, of the herpes-type virus of Marek's disease (strain HPRS-16) on passage in cell culture. J Gen Virol. 1969 Jun;4(4):557–564. doi: 10.1099/0022-1317-4-4-557. [DOI] [PubMed] [Google Scholar]
  7. Eidson C. S., Anderson D. P., Kleven S. H., Brown J. Field trials of vaccines for Marek's disease. Avian Dis. 1971 Apr-Jun;15(2):312–322. [PubMed] [Google Scholar]
  8. Jakowski R. M., Fredrickson T. N., Chomiak T. W., Luginbuhl R. E. Hematopoietic destruction in Marek's disease. Avian Dis. 1970 May;14(2):374–385. [PubMed] [Google Scholar]
  9. Kawamura H., King D. J., Jr, Anderson D. P. A herpesvirus isolated from kidney cell culture of normal turkeys. Avian Dis. 1969 Nov;13(4):853–863. [PubMed] [Google Scholar]
  10. Patrascu I. V., Calnek B. W., Smith M. W. Vaccination with lyophilized turkey herpesvirus (HVT): minimum infective and protective doses. Avian Dis. 1972 Apr;16(1):86–93. [PubMed] [Google Scholar]
  11. Purchase H. G., Okazaki W., Burmester B. R. Field trials with the herpes virus of turkeys (HVT) strain FC126 as a vaccine against Marek's disease. Poult Sci. 1971 May;50(3):775–783. doi: 10.3382/ps.0500775. [DOI] [PubMed] [Google Scholar]
  12. Purchase H. G., Okazaki W. Effect of vaccination with herpesvirus of turkeys (HVT) on horizontal spread of Marek's disease herpesvirus. Avian Dis. 1971 Apr-Jun;15(2):391–397. [PubMed] [Google Scholar]
  13. Purchase H. G. Recent advances in the knowledge of Marek's disease. Adv Vet Sci Comp Med. 1972;16:223–258. [PubMed] [Google Scholar]
  14. Rispens B. H., van Vloten H., Mastenbroek N., Maas H. J., Schat K. A. Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials. Avian Dis. 1972 Apr;16(1):108–125. [PubMed] [Google Scholar]
  15. Rispens B. H., van Vloten H., Mastenbroek N., Maas J. L., Schat K. A. Control of Marek's disease in the Netherlands. II. Field trials on vaccination with an avirulent strain (CVI 988) of Marek's disease virus. Avian Dis. 1972 Apr;16(1):126–138. [PubMed] [Google Scholar]
  16. Vielitz E., Landgraf H. Impfversuche gegen Marek'sche Krankheit unter Verwendung von attenuiertem Marek-Herpes-Virus und Puten-Herpes-Virus. Dtsch Tierarztl Wochenschr. 1971 Dec 1;78(23):617–623. [PubMed] [Google Scholar]
  17. Witter R. L., Nazerian K., Purchase H. G., Burgoyne G. H. Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus. Am J Vet Res. 1970 Mar;31(3):525–538. [PubMed] [Google Scholar]
  18. von Bülow V. Diagnosis and certain biological properties of the virus of Marek's disease. Am J Vet Res. 1971 Aug;32(8):1275–1288. [PubMed] [Google Scholar]

Articles from The British Journal of Cancer. Supplement are provided here courtesy of Cancer Research UK

RESOURCES